These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12353187)

  • 1. Progress in meeting today's demands in genital herpes: an overview of current management.
    Patel R
    J Infect Dis; 2002 Oct; 186 Suppl 1():S47-56. PubMed ID: 12353187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on drugs for herpes zoster and genital herpes.
    Drug Ther Bull; 1998 Oct; 36(10):77-9. PubMed ID: 10194872
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
    Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
    Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in genital herpes simplex virus management.
    Corey L
    J Infect Dis; 2002 Oct; 186 Suppl 1():S29-33. PubMed ID: 12353184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
    Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
    Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital herpes: antiviral therapy for symptom relief and prevention of transmission.
    Gupta R; Wald A
    Expert Opin Pharmacother; 2006 Apr; 7(6):665-75. PubMed ID: 16556084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of common cutaneous herpes simplex virus infections.
    Emmert DH
    Am Fam Physician; 2000 Mar; 61(6):1697-706, 1708. PubMed ID: 10750877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment of genital herpes.
    Apoola A; Radcliffe K
    Int J STD AIDS; 2004 Jul; 15(7):429-33. PubMed ID: 15228725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections.
    ACOG Committee on Practice Bulletins--Gynecology
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1111-8. PubMed ID: 15516420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.
    Lebrun-Vignes B; Bouzamondo A; Dupuy A; Guillaume JC; Lechat P; Chosidow O
    J Am Acad Dermatol; 2007 Aug; 57(2):238-46. PubMed ID: 17416440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on antiviral therapy for genital herpes infection.
    Geers TA; Isada CM
    Cleve Clin J Med; 2000 Aug; 67(8):567-73. PubMed ID: 10946451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in the antiviral treatment of genital herpes.
    Cheong WK
    Ann Acad Med Singap; 1995 Jul; 24(4):593-7. PubMed ID: 8849194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.